Quest Diagnostics Incorporated Share Price

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 21:00:02 24/06/2024 BST 5-day change 1st Jan Change
140.2 USD +0.91% Intraday chart for Quest Diagnostics Incorporated +2.34% +1.70%
Sales 2024 * 9.45B 744B Sales 2025 * 9.76B 770B Capitalization 15.58B 1,228B
Net income 2024 * 895M 70.54B Net income 2025 * 970M 76.45B EV / Sales 2024 * 2.08 x
Net Debt 2024 * 4.04B 319B Net Debt 2025 * 3.58B 282B EV / Sales 2025 * 1.96 x
P/E ratio 2024 *
18 x
P/E ratio 2025 *
16.5 x
Employees 44,000
Yield 2024 *
2.09%
Yield 2025 *
2.12%
Free-Float 68.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.91%
1 week+2.34%
Current month-1.23%
1 month-0.74%
3 months+8.45%
6 months+2.55%
Current year+1.70%
More quotes
1 week
135.82
Extreme 135.82
140.58
1 month
135.82
Extreme 135.82
143.84
Current year
123.04
Extreme 123.04
145.62
1 year
119.59
Extreme 119.59
145.62
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
56.27
Extreme 56.27
174.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/03/13
Director of Finance/CFO 54 10/07/22
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 17/02/19
Director/Board Member 66 06/12/11
Director/Board Member 74 30/11/04
More insiders
Date Price Change Volume
24/06/24 140.2 +0.91% 599,412
21/06/24 139 +0.55% 908,537
20/06/24 138.2 +0.66% 758,495
18/06/24 137.3 +0.20% 759,682

Delayed Quote Nyse, June 24, 2024 at 09:00 pm

More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140.2 USD
Average target price
147 USD
Spread / Average Target
+4.83%
Consensus